Non-Enzymatic Debriding Agent for Gentle Eschar Dissolution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for debriding chronic wounds, such as enzymatic and surgical debridement, are costly, painful, and cause adverse side effects like inflammation and discomfort, necessitating a more effective and economical alternative.
Innovation Solution
A non-enzymatic debriding agent using a gentle non-ionic detergent with high critical micelle concentration and a natural denaturing agent to denature and dissolve necrotic tissue, combined with a wound dressing to facilitate removal, potentially enhanced by micro/nano particles and antimicrobial agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If enzymatic debridement is used, then necrotic tissue removal is achieved, but treatment cost increases and adverse side effects occur
Solution Approach 1:
The patent replaces enzymatic debridement with a mechanical/physical approach using a scalpel and forceps for surgical debridement, or alternatively uses a non-enzymatic chemical solution with detergent and denaturant components to dissolve necrotic tissue without the harmful inflammatory effects of enzymatic methods
Solution Approach 2:
The patent changes the chemical parameters by using a non-enzymatic solution containing specific concentrations of detergent (0.1-10%), denaturant (5-50%), and other active ingredients, achieving effective necrotic tissue dissolution without the harmful side effects of traditional enzymatic debridement
2Reliability
If surgical debridement is used, then necrotic tissue removal is achieved, but pain and treatment cost increase
Solution Approach 1:
The patent replaces painful mechanical surgical debridement with a chemical solution-based approach that dissolves necrotic tissue autonomously, eliminating the need for invasive scraping and reducing patient pain during the debridement process
Solution Approach 2:
The chemical solution enables the wound to debride itself through dissolution of necrotic tissue, eliminating the need for manual intervention and reducing pain associated with surgical debridement procedures
3Reliability
If enzymatic debridement is used, then necrotic tissue removal is achieved, but treatment duration increases
Solution Approach 1:
The patent optimizes the concentration and composition parameters of the debridement solution (detergent 0.1-10%, denaturant 5-50%, and other active ingredients) to accelerate the dissolution rate of necrotic tissue, reducing treatment duration compared to standard enzymatic debridement
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The agent effectively dissolves necrotic tissue in less than 14 days, reducing treatment time and cost, and minimizing side effects compared to enzymatic methods, with formulations suitable for use in advanced wound dressings.
Implementation Method 1
The mechanism of action involves a three-step process to non-enzymatically debride the necrotic eschar material. The first step involves rehydration and denaturation of the necrotic material with a denaturant.
Implementation Method 2
The second step involves the solubilization of the denatured material, such as by a gentle detergent with a high critical micelle concentration (High CMC).
Implementation Method 3
in step three this material can be easily wicked away from the surface into a wound dressing
Data Source
AI summary
A non-enzymatic debridement agent that is less expensive, less cytotoxic, and more effective than enzymatic and sharp surgical debridement of eschar material. The non-enzymatic debridement agent is based on a formulation of detergent with a high critical micelle concentration and a denaturing agent along with an optional optimized buffer. The non-enzymatic wound debriding agent is able to dissolve eschar material in under one week. The buffer or ointment may contain an optimized pH, salt concentration, reducing agent, and other components that aid in the debridement of eschar material from chronic wounds and burn wounds. The non-enzymatic debridement agent can be formulated as an ointment, liquid rinse under pressure, and/or as a combination product with an advanced wound dressing that can act as a sink to remove the solubilized eschar material from the surface of the wound to assist in the debridment and proper healing of wounds.